ABSTRACT
Importance The absence of a reliable marker of early-stage knee osteoarthritis (KOA) represents a missed opportunity to develop interventions that restore joint integrity. The use of ultrasonography (US) to measure fat infiltration of muscle, which has been associated with incidence and progression of KOA, is one possible solution. Summarizing the trajectory of fatty infiltration during natural aging and KOA processes and establishing US-implementation as a tool for the early diagnosis of KOA represent essential first steps.
Objective (1) To summarize the alterations in quadriceps muscle quality during healthy aging (young vs. older) and in the setting of KOA (older vs. KOA) using computational approaches, and (2) to validate and translate these findings by applying US assessment of muscle quality in a clinical setting.
Design, Setting, Participants Systematic review with network meta-analysis integrated with a subsequent case-control validation study in an orthopedic clinic. Both analyses evaluated three groups: healthy young, healthy older, and individuals with KOA.
Main outcome and Measures Quadriceps muscle quality assessed by US.
Results Data from a total of 718 healthy aging individuals (young, n = 336; old, n = 382) and 1,046 individuals with KOA (old, n = 625; KOA, n = 421) were synthesized for meta-analyses. As determined by US, older adults displayed poor quadriceps muscle quality compared to young; this decline was significantly exacerbated when individuals had KOA. The network meta-analysis revealed that the presence of KOA significantly accelerated muscle fatty infiltration compared to natural aging. Notably, US findings were comparable to gold-standard imaging modalities of both MRI and CT for fat infiltration in skeletal muscle. The findings from these computational analyses were supported by an US-implemented validation study in a clinical setting, which also identified the vastus medialis as the most sensitive quadricep muscle to predict both the onset and development of KOA.
Conclusions and Relevance This study established accelerated fat deposition in the vastus medialis as a distinct marker for early KOA, as reliably identified by US. These findings expand opportunities for the early diagnosis and treatment for KOA in a clinical setting given the increased cost-efficiency and accessibility of the US system compared to MRI or CT.
Trial registration PROSPERO Identifier: CRD 42022380856
Question Does ultrasonography identify distinct declines in quadriceps muscle quality related to age and knee osteoarthritis (KOA)?
Findings A hybrid approach of network meta-analysis (1,794 participants) followed by ultrasound assessment revealed that KOA significantly accelerated aging-induced fat infiltration in muscle. This study suggests that the 10-year rate of decline in quadriceps muscle quality in KOA is greater than in healthy aging. Furthermore, these changes can sensitively be assessed by ultrasonography.
Meaning Fatty infiltration in the quadriceps muscle over the course of natural aging is accelerated in the setting of KOA. Such trajectories are assessable using ultrasonography, a valuable approach to identify adults at risk for KOA.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=380856
Funding Statement
This study was funded by a JSPS KAKENHI (Grant-in-Aid for Early-Career Scientists; Grant Number: 18045240) from the Japan Society for the Promotion of Science.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics Committee of the Medical Corporation Nagomi gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.